Approval · Notice of Compliance 38259 · 2026
SEROSTIM: Notice of Compliance 38259
Issued September 10, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38259
- Date
- September 10, 2026
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- 1. Drug substance manufacturing process change 2. New formulation suite 3. Drug product manufacturing process change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEROSTIM | Not yet assigned | — |
Medicinal ingredients
- SOMATROPIN 5 MG per VIAL